Senior insider sale
EVP & Chief Financial Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$245.3K
25K shares
What this filing means
O'BYRNE JASON plans to sell 25K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $245.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2026ACC: 0001959173-26-006329
Officer· EVP & Chief Financial Officer
Since Feb 2026
25K
Shares to sell
$245.3K
Approx. market value
25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/21/2026
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2026 | Stock Option Exercise Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
25K
Market value
$245.3K
8/21/2026
Total
Units
25K
Value
$245.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2026 | 25K | $245.3K | NASDAQ | Planned |
| Total | 25K | $245.3K | ||